Drawing for PLATBIO

USPTO serial 79264691

PLATBIO

Reviewed by CopyMark Law Group

Reg. 5934748Status 709
Filing date
Status date
Registration date
Dec 17, 2019
Examiner
FIONDA, LAURA ELIZABETH
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with PLATBIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical products for the treatment of viral diseases; anti-inflammatory analgesic preparations; pharmaceutical preparations for treating malignant tumours; pharmaceutical preparations and compositions for the treatment and prevention of cancer; pharmaceutical preparations and substances for the prevention of cancer; pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; biopharmaceuticals for the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; capsules for medicines; gastro-intestinal treatment preparations; diagnostic preparations for medical or veterinary purposes; diagnostic preparations for medical purposes for detecting genetic predispositions; diagnostic test reagents for medical purposes; in vitro diagnostic preparations for medical purposes; diagnostic reagents for medical purpose; pharmaceuticals; clinical diagnostic reagents; pharmaceutical preparations for targeted therapy of tumors; pharmaceutical preparations for suppressing tumors; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations for use in oncology; diagnostic biomarker reagents for medical purposes; pharmaceutical preparations for diagnosis; radio-isotope markers for therapeutic or diagnostic use; therapeutic drugs and agents; dermatological pharmaceutical products; tumor suppressing agents; pharmaceutical preparations for respiratory organsSECTION 71 - CANCELLED—
044Pharmacy advice; preparation and dispensing of medications; medical consultancy for selecting appropriate medicines; information services relating to medical productsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 3, 2026C71TCANCELLED SECTION 71—
Feb 21, 2020GPNXNOTIFICATION PROCESSED BY IB—
Feb 6, 2020FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 6, 2020FIMPFINAL DISPOSITION PROCESSED—
Jan 16, 2020GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Dec 17, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 12, 2019GPNXNOTIFICATION PROCESSED BY IB—
Oct 1, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 25, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 25, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 11, 2019NPUBNOTICE OF PUBLICATION—
Aug 27, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 21, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 17, 2019DOCKASSIGNED TO EXAMINER—
Aug 17, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 8, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance